We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.07%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$7.57B
AUM Growth
+$643M
(+9.3%)
Cap. Flow
+$235M
Cap. Flow
% of AUM
3.1%
Top 10 Holdings %
Top 10 Hldgs %
16.13%
Holding
1,154
New
305
Increased
228
Reduced
235
Closed
370
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$71M |
| 2 |
Baxter International
BAX
|
+$60.7M |
| 3 |
T-Mobile US
TMUS
|
+$60.1M |
| 4 |
Perrigo
PRGO
|
+$53.7M |
| 5 |
NRG Energy
NRG
|
+$50.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$68.2M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$53.3M |
| 3 |
Avient
AVNT
|
+$45.7M |
| 4 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$45.6M |
| 5 |
BHI
Baker Hughes
BHI
|
+$40.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.11% |
| 2 | Industrials | 11.84% |
| 3 | Consumer Discretionary | 11.65% |
| 4 | Technology | 10.61% |
| 5 | Financials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Expedia Group
EXPE
$38.4B
| $5.24M | 0.07% |
+61,332
| New | +$5.2M |
|
|
NRF
302
DELISTED
NorthStar Realty Finance Corp.
NRF
| $5.23M | 0.07% |
148,761
+130,546
| +717% | +$4.65M |
|
303
Intuit
INTU
$89.7B
| $5.21M | 0.07% |
56,485
-56,959
| -50% | -$5.07M |
|
304
NETSCOUT
NTCT
$2.98B
| $5.2M | 0.07% |
142,358
+73,132
| +106% | +$2.76M |
|
|
YELL
305
DELISTED
Yellow Corporation Common Stock
YELL
| $5.2M | 0.07% |
+231,087
| New | +$4.95M |
|
306
Ciena
CIEN
$57.9B
| $5.12M | 0.07% |
263,987
+62,825
| +31% | +$1.05M |
|
|
GWR
307
DELISTED
Genesee & Wyoming Inc.
GWR
| $5.12M | 0.07% |
56,916
+42,418
| +293% | +$3.92M |
|
|
KANG
308
DELISTED
iKang Healthcare Group, Inc.
KANG
| $5.09M | 0.07% |
+338,589
| New | +$6.03M |
|
|
MW
309
DELISTED
THE MENS WAREHOUSE INC
MW
| $5.07M | 0.07% |
+114,866
| New | +$5.18M |
|
310
Ligand Pharmaceuticals
LGND
$6.06B
| $5.06M | 0.07% |
152,490
-158,782
| -51% | -$5.17M |
|
311
Nexstar Media Group
NXST
$5.8B
| $5.05M | 0.07% |
+97,535
| New | +$4.51M |
|
312
Booz Allen Hamilton
BAH
$8.65B
| $5.01M | 0.07% |
188,872
+108,370
| +135% | +$2.81M |
|
313
Clearwater Paper
CLW
$367M
| $4.95M | 0.07% |
72,227
+2,567
| +4% | +$171K |
|
314
Golar LNG
GLNG
$5.11B
| $4.9M | 0.06% |
134,274
-5,403
| -4% | -$257K |
|
315
Seagate
STX
$190B
| $4.84M | 0.06% |
72,724
-440,197
| -86% | -$27.3M |
|
316
Cogent Communications
CCOI
$644M
| $4.83M | 0.06% |
+136,367
| New | +$4.57M |
|
|
GPOR
317
DELISTED
Gulfport Energy Corp.
GPOR
| $4.75M | 0.06% |
113,677
+106,922
| +1,583% | +$5M |
|
|
ZOES
318
DELISTED
Zoe's Kitchen, Inc.
ZOES
| $4.74M | 0.06% |
+158,448
| New | +$5.13M |
|
|
AVDL
319
DELISTED
Avadel Pharmaceuticals
AVDL
| $4.73M | 0.06% |
275,983
+161,656
| +141% | +$2.31M |
|
320
Minerals Technologies
MTX
$2.4B
| $4.72M | 0.06% |
68,016
-74,799
| -52% | -$5.2M |
|
|
HRC
321
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $4.67M | 0.06% |
102,353
-122,038
| -54% | -$5.41M |
|
|
GLOG
322
DELISTED
GASLOG LTD
GLOG
| $4.61M | 0.06% |
+226,722
| New | +$4.45M |
|
|
HOT
323
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
| $4.61M | 0.06% |
56,891
+1,016
| +2% | +$79.3K |
|
|
STJ
324
DELISTED
St Jude Medical
STJ
| $4.56M | 0.06% |
+70,180
| New | +$4.52M |
|
325
Equinix
EQIX
$104B
| $4.54M | 0.06% |
20,033
+17,871
| +827% | +$3.86M |
|
Similar funds
Marshall Wace's Q4 2014 Portfolio in Review
As of Q4 2014, Marshall Wace held 1,154 positions worth $7.57B, up 9.3% from $6.93B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $235M of net new capital in Q4 2014, opening 305 new positions and adding to 228 existing holdings. Its largest new stake was Baxter International: 1,557,838 shares worth $62M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Alibaba, an estimated $68.2M trimmed.
- Marshall Wace's largest Q4 2014 buy was Baxter International: 1,557,838 shares worth $62M.
- Marshall Wace added most to Allergan Inc in Q4 2014, an estimated $71M increase.
- Marshall Wace's biggest Q4 2014 reduction was Alibaba, cutting an estimated $68.2M.
- Marshall Wace fully exited Baker Hughes in Q4 2014, selling an estimated $40.5M.
- Marshall Wace's ten largest holdings make up 16% of its $7.57B portfolio in Q4 2014.
- Marshall Wace opened 305 new positions and closed 370 in Q4 2014.
- Marshall Wace's portfolio value rose 9.3% quarter-over-quarter to $7.57B.
Based on Marshall Wace's 13F filing for Q4 2014, filed 17 Feb 2015.